ELM STREET VENTURES: PORTFOLIO Company Profiles ; AllAcquired/ExitedActiveInactive/Closed Nanoparticle-based therapies for the treatment of cancer and other diseases Transfection of nucleic acids and other particles into living cells for therapeutic cell therapy Therapeutics for Novel Immune System Targets Therapeutic drug platform Medical device for cartilage repair Rapid production of antibodies for research, diagnostics, and therapeutics. Acquired by Illumina. High speed detection of pathogens for food safety. Targeting diseases involving the human intestinal microbiota Developing therapeutics based on protein degradation platform. Recombinant antibodies for research and diagnostic markets. Acquired by Abcam. Antibiotic therapeutics. Math education software. Data center information management software. Therapeutics for ophthalmic disease. Cancer therapeutics targeting RTKs. Developed assays for mining the metagenome for therapeutics. Employed the tools of green chemistry to redesign drugs. Therapeutic targeting Chemotherapy Induced Peripheral Neuropathy (CIPN). Specialty chemical company using proprietary ozonolysis process. Space optimization software for large retailers. Acquired by Revionics. Athletic apparel for female athletes providing protection from injury and enhanced performance. High power, high efficiency, low cost LEDs. Advanced tablet and mobile software platform for enterprise applications. Citizen engagement and workflow software for towns and cities. Social networking for groups, integrating real time communication, multimedia, and web content. Acquired by Facebook.